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PAPD5, a noncanonical poly(A) polymerase
with an unusual RNA-binding motif
CHRISTIANE RAMMELT,1,3 BITER BILEN,2 MIHAELA ZAVOLAN,2 and WALTER KELLER2,3
1Institute of Biochemistry and Biotechnology, Martin Luther University Halle-Wittenberg, D-06099 Halle, Germany
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ABSTRACT
PAPD5 is one of the seven members of the family of noncanonical poly(A) polymerases in human cells. PAPD5 was shown to
polyadenylate aberrant pre-ribosomal RNAs in vivo, similar to degradation-mediating polyadenylation by the noncanonical
poly(A) polymerase Trf4p in yeast. PAPD5 has been reported to be also involved in the uridylation-dependent degradation of
histone mRNAs. To test whether PAPD5 indeed catalyzes adenylation as well as uridylation of RNA substrates, we analyzed the
in vitro properties of recombinant PAPD5 expressed in mammalian cells as well as in bacteria. Our results show that PAPD5
catalyzes the polyadenylation of different types of RNA substrates in vitro. Interestingly, PAPD5 is active without a protein
cofactor, whereas its yeast homolog Trf4p is the catalytic subunit of a bipartite poly(A) polymerase in which a separate RNA-
binding subunit is needed for activity. In contrast to the yeast protein, the C terminus of PAPD5 contains a stretch of basic amino
acids that is involved in binding the RNA substrate.
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INTRODUCTION
The addition of a poly(A) tail to the 39 end of mRNAs in
the nucleus of eukaryotic cells is catalyzed by the classical or
canonical poly(A) polymerases (PAPs) and is an important
step during mRNA maturation. The poly(A) tail confers
stability to the mRNA and allows transport out of the
nucleus and efficient translation in the cytoplasm. In con-
trast, the functions of the so-called noncanonical PAPs or
Cid1-like proteins (after the founding member of the family)
are only partially understood. Enzymes of this group are
involved in cytoplasmic polyadenylation of mRNAs, but
also in polyadenylation-mediated degradation of RNAs,
and some members of the family even catalyze the addition
of uridyl residues to RNA substrates (Schmidt and Norbury
2010). Like the canonical PAPs, Cid1-like proteins belong
to the superfamily of polymerase b-like nucleotidyl trans-
ferases. Canonical and noncanonical PAPs have similar
catalytic and central domains but differ in their nucleotide-
base recognition motif. Interestingly, only a few Cid1-like
proteins contain an RNA-binding domain (Martin and
Keller 2007).
One well-studied member of the Cid1-like protein family
is Trf4p, a PAP involved in nuclear RNA surveillance in
Saccharomyces cerevisiae. Polyadenylation of RNAs by Trf4p
facilitates their subsequent degradation by the nuclear
exosome, a 39–59 exonuclease complex (Kadaba et al.
2004, 2006; Vanacova et al. 2005), or in some cases induces
the processing of the RNA by exosome-catalyzed trimming
of the 39 end (Egecioglu et al. 2006). A stimulatory effect of
polyadenylation on the exosome activity was first shown to
allow efficient degradation of a hypomodified, unstable
tRNA (LaCava et al. 2005; Vanacova et al. 2005). Later,
rRNAs, snRNAs, and snoRNAs, as well as so-called cryptic
unstable transcripts (CUTs), spliced-out introns, and different
mRNAs were identified as substrates of this polyadenylation-
mediated RNA quality-control mechanism (LaCava et al.
2005; Wyers et al. 2005; Davis and Ares 2006; Dez et al.
2006; Egecioglu et al. 2006; Carneiro et al. 2007; Houseley
et al. 2007; San Paolo et al. 2009; Callahan and Butler
2010).
Trf4p lacks an RNA-binding domain and is therefore
inactive on its own. In vivo it is part of the TRAMP4
complex that contains Trf4p as the catalytic subunit, one of
the zinc knuckle proteins Air1p or Air2p, thought to confer
the RNA-binding function to the complex, and the RNA
helicase Mtr4p (LaCava et al. 2005; Vanacova et al. 2005).
A similar complex, SpTRAMP, was identified in fission
yeast (Win et al. 2006; Bu¨hler et al. 2008). In Drosophila
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melanogaster, overexpression of a homolog of Trf4p was shown
to lead to the polyadenylation of snRNAs (Nakamura et al.
2008), whereas the human homolog PAPD5 is involved in
the polyadenylation-mediated degradation of aberrant pre-
rRNAs (Shcherbik et al. 2010).
The human PAPD5 protein was also reported to func-
tion in the degradation of replication-dependent histone
mRNAs. These mRNAs do not have a poly(A) tail but end
in a stem–loop structure. Here, however, the degradation
pathway does not start with polyadenylation of the RNA,
but with the addition of a short oligo(U) tail, which is
recognized by the Lsm1-7 complex and subsequently leads
to decapping and degradation of the mRNAs. A knock-
down of either PAPD5 or of the mitochondrial poly(A)
polymerase results in the stabilization of histone mRNAs
(Mullen and Marzluff 2008). However, this effect could not
be observed by other investigators (Schmidt et al. 2010).
Instead, the knockdown of the uridyl transferase ZCCHC11,
a different member of the human Cid1-like proteins, was
shown to strongly reduce the oligouridylation of histone
mRNAs, leading to their stabilization (Schmidt et al. 2010). It
is therefore possible that PAPD5, depending on the RNA
substrate or the presence of different protein cofactors, can
catalyze the polyadenylation as well as the oligouridylation of
RNAs. To better understand the function of PAPD5, we set
out to investigate the activity of the protein in vitro and to
explore its function in mammalian cells through cross-linking
and immunoprecipitation (CLIP) (Hafner et al. 2010).
RESULTS
PAPD5 is a poly(A) polymerase in vitro
PAPD5 (UniProt accession number Q8NDF8) is involved in
the polyadenylation of aberrant ribosomal RNA precursors
in mouse (Shcherbik et al. 2010). In addition, it may also be
responsible for the uridylation-mediated degradation of
histone mRNAs (Mullen and Marzluff 2008). However, this
function of PAPD5 is controversial (Schmidt et al. 2010). To
test the activity of PAPD5 in vitro, the coding sequence was
amplified from cDNA of HeLa cells. The protein was
expressed in HEK293 cells as a fusion protein with an
N-terminal Flag tag and a His8 tag. After cell lysis, the
protein was bound to anti-Flag agarose, washed, and eluted
with Flag peptide. The protein was further purified via nickel
affinity chromatography (Fig. 1A).
To test the nucleotidyltransferase activity of PAPD5, the
oligoribonucleotide A15 was incubated with the protein
either in the presence of ATP, CTP, GTP, or UTP, or in
a mixture of all four dNTPs (Fig. 2A). When PAPD5 and
A15 were incubated in the presence of ATP, the incorpo-
ration of several nucleotides into the RNA substrate was
observed. In contrast, the incorporation of the other three
ribonucleotides was low and limited to single residues,
showing a strong preference of PAPD5 for ATP. In
addition, PAPD5 is able to discriminate against dNTPs,
as these were not used as substrates.
PAPD5 does not need a cofactor for polyadenylation
in vitro
To further analyze the properties of PAPD5, the protein
was expressed in Escherichia coli. To prevent contamination
with bacterial poly(A) polymerase, an expression strain
with a disruption in the gene for poly(A) polymerase was
used. Two PAPD5 expression constructs were tested: a His6
fusion and a combination of a C-terminal His6 tag and an
N-terminal fusion of a GB1 tag that was shown to increase
the solubility of recombinant proteins (Zhou et al. 2001).
Because the activity of both wild-type fusion proteins was
the same but the yield of the GB1-tagged protein was
higher, the latter construct was used for further experi-
ments. The purified protein is shown in Figure 1B.
Trf4p, the poly(A) polymerase of the TRAMP4 complex
in baker’s yeast, was previously shown to be inactive on its
own. Trf4p contains no obvious RNA-binding domain and
is believed to rely on the zinc-knuckle proteins Air1p or
Air2p as the substrate-binding domain of the complex.
Indeed, only the combination of Trf4p with either Air1p or
Air2p has poly(A) polymerase activity (LaCava et al. 2005;
Vanacova et al. 2005).
Surprisingly, the bacterially expressed PAPD5 (Fig. 1B)
showed the same activity as the protein purified from
HEK293 cells. When the ribo-oligonucleotide A15 was
incubated with PAPD5 in the presence of different nucle-
otides, efficient incorporation could only be observed with
ATP (Fig. 2A). A PAPD5 variant in which two aspartate
residues (D177, D179) in the catalytic domain were
exchanged to alanine could not catalyze the addition of
nucleotides to the RNA substrate (PAPD5 DADA) (Fig.
2B). Therefore, the observed polyadenylation activity is an
FIGURE 1. PAPD5 preparations used in the analysis. (A) PAPD5 was
expressed as a fusion protein with N-terminal His8 and Flag tag in
HEK293 cells and purified via anti-Flag agarose (Flag), followed by metal
chelating affinity chromatography (Flag + NiNTA). PAPD5 is marked by
an arrowhead. (B) Bacterially expressed PAPD5 after metal chelating
affinity chromatography (for details, see Materials and Methods).
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intrinsic activity of PAPD5, and a protein cofactor is not
needed for activity.
The nucleotide incorporation experiment was repeated
with other RNA substrates: Ribo-oligonucleotide G2U15 was
used to test whether the last nucleotide of the RNA primer
influences the specificity for the nucleotide substrate (Fig.
2C). In addition, in vitro–synthesized tRNAi
Met (a known
substrate for yeast Trf4p) and an in vitro–synthesized
fragment of the 39 UTR of mouse histone H2a mRNA
comprising the stem–loop structure were tested as substrates
(results not shown). Again, only AMP incorporation could
be observed. Therefore, the specificity for ATP incorporation
does not depend on the last nucleotide of the RNA primer
but results from nucleotide specificity of the protein. The
specificity for ATP incorporation was also observed when
a reaction buffer containing manganese instead of magne-
sium was used (results not shown).
As reported for yeast Trf4p (LaCava et al. 2005), the
polyadenylation reaction catalyzed by PAPD5 is not pro-
cessive: In all cases, the reaction products were heteroge-
neous in size, the smallest product usually corresponding
to the incorporation of a single nucleotide. When DNA
oligonucleotides were used as primers, none of the nucle-
otide substrates was incorporated (results not shown),
showing that the reaction is RNA-specific.
A C-terminal stretch of basic amino acids is involved
in binding of the RNA primer
The amino acid sequence of PAPD5 does not contain any
motif known to bind nucleic acids. However, the poly-
adenylation activity of PAPD5 observed in vitro and in the
absence of other protein cofactors ar-
gues for the presence of a domain in the
protein that is involved in binding of
the RNA substrate. To analyze the RNA
binding of PAPD5, electrophoretic mo-
bility shift experiments were performed.
PAPD5 was incubated with in vitro–
synthesized tRNA, and the reaction
mixture was resolved on a nondenatur-
ing polyacrylamide gel. Indeed, a shift
of the RNA band to a band of lower
mobility could be observed, showing
that PAPD5 is able to bind RNA. To
determine which part of the protein is
responsible for RNA binding, protein
variants comprising only the N termi-
nus including the catalytic domain
(amino acids 1–111, PAPD5 N), the
central domain (amino acids 112–368,
PAPD5 M), or the C terminus of
PAPD5 (amino acids 369–572, PAPD5
C1) were analyzed separately. Of these,
only the C-terminal part, PAPD5 C1,
could shift the tRNA (Fig. 3), indicating the presence of an
RNA-binding function in the C terminus of PAPD5.
Inspection of the amino acid sequence showed the C
terminus of human PAPD5 to contain a stretch of basic
amino acids (amino acids 557–563), a motif that is
conserved among higher eukaryotes, but not in the yeast
protein Trf4p (Fig. 4). To test the influence of the basic
motif on the RNA-binding ability of PAPD5, a deletion
variant of the C-terminal part lacking this motif was used
(amino acids 369–551, PAPD5 C2). Whereas the C termi-
nus binds to RNA (Fig. 3, PAPD5 C1), the deletion variant
showed no shift of the RNA in EMSA experiments, even
when used in higher concentrations than the original
C-terminal fragment (Fig. 3, PAPD5 C2).
Next, we wanted to analyze the influence of this basic
amino acid stretch on the catalytic activity of PAPD5.
Therefore, a protein variant PAPD5DC, comprising amino
acids 1–551, i.e., lacking only the basic stretch, was
constructed and tested for polyadenylation activity. In
addition, a point mutant of PAPD5 was constructed in
which a lysine residue in the basic domain was exchanged
to glutamate (PAPD5 K560E). The variants were expressed
in E. coli and purified as the wild-type protein. For both
variants, the yield of soluble protein was comparable to the
wild type. In comparison to the wild-type protein, both
variants showed a reduced activity when incubated with the
A15 substrate in the presence of ATP, resulting in fewer
incorporated nucleotides and therefore shorter polyadeny-
lation products (Fig. 5).
To further examine the influence of the basic stretch of
amino acids on the polyadenylation activity of PAPD5, the
wild-type protein and the variants were incubated with
FIGURE 2. PAPD5 preferentially adds AMP residues to RNA substrates. (A) PAPD5
preparations from HEK293 cells (HEK293) or recombinant protein expressed in E. coli
(rec.) were incubated with ribo-oligonucleotide A15 in the presence of ATP (A), CTP (C), GTP
(G), UTP (U), or a mixture of all four dNTPs (dN), respectively. (B) PAPD5 wild-type protein
(wt) or catalytic site mutant (DADA) expressed in E. coli were incubated with ribo-
oligonucleotide A15 in the presence of ATP. (C) PAPD5 expressed in E. coli was incubated
with ribo-oligonucleotide G2U15 in the presence of ATP (A), CTP (C), GTP (G), UTP (U), or
a mixture of all four dNTPs (dN), respectively. Lane 1 always shows the RNA substrate
incubated in the absence of protein.
The noncanonical poly(A) polymerase PAPD5
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different concentrations of either ATP or A15 substrate to
determine the kinetic parameters of the reaction. To this
end, radioactive ATP was used as nucleotide substrate, and
the radioactively labeled reaction products were separated
from nonincorporated nucleotides with DE81 filters. The
polyadenylation activity was measured as total incorpora-
tion of nucleotides into the A15 substrate, independent of
the length of the resulting product.
When the concentration of the RNA substrate A15 was
varied, the maximal velocities for the wild-type protein and
the variants were similar (Table 1). However, the KM of the
proteins with changes in the C-terminal basic motif was
increased by a factor of z3 to 5. In contrast, there was no
significant difference in the apparent affinity for ATP. The
concentration of ATP during A15 titration was in much higher
excess than the concentration of the RNA
primer when ATP was titrated; therefore,
the kcat values determined by titration of
ATP are lower than the values observed
for the titration of A15. This result con-
firms the participation of the stretch of
basic amino acids in the binding of the
RNA substrate by PAPD5.
Specificity for RNA structure
The yeast TRAMP complex was shown
to specifically polyadenylate unmodified
initiator tRNA, but not the native and
therefore fully modified tRNA (Vanacova
et al. 2005). This is thought to be a result
of a more compact tertiary structure of
the native tRNA. It was shown recently
that a core complex consisting of the
central part of Trf4p and two out of the
five zinc knuckles of Air2p is sufficient
to discriminate between the two tRNA
substrates (Hamill et al. 2010). To test
whether PAPD5 shows a similar ability, PAPD5 purified
from HEK293 cells as well as bacterially expressed PAPD5
were incubated with either in vitro–synthesized yeast
tRNAi
Met or the native tRNA purified from yeast cells in the
presence of ATP. Interestingly, both enzyme preparations were
able to polyadenylate the in vitro transcript but not the native
tRNA, whereas at the same time E. coli poly(A) polymerase
polyadenylated both tRNA substrates (Fig. 6; results not
shown). Therefore, similarly to the yeast Trf4p, PAPD5
seems to be sensitive to the structure of the RNA substrate.
Subcellular localization of PAPD5
In yeast, Trf4p is part of a RNA surveillance machinery
residing in the nucleus. To determine the localization of
FIGURE 3. The C terminus of PAPD5 is involved in RNA binding. (A) Schematic
representation of the truncation variants of PAPD5 tested for RNA binding. (B) Electropho-
retic mobility shift assay of PAPD5 variants. Increasing amounts of PAPD5 full-length protein
or fragments comprising the N terminus, central part, or C terminus of the protein were
incubated with radioactively labeled in vitro–synthesized human tRNAi
Met, and the reactions
were resolved on a native polyacrylamide gel. Protein concentrations between 0.5 and 5 nM
were tested for the full-length protein and the protein PAPD5 C2, 1–20 nM for the other
variants. Lane 1 shows the tRNA after incubation in the absence of protein.
FIGURE 4. The basic motif in the C terminus of PAPD5 is conserved among higher eukaryotes. Amino acid sequences of PAPD5 homologs
(Ensembl) were aligned with ClustalW (Chenna et al. 2003) and refined manually (upper panel). The amino acid sequence of the yeast protein
Trf4p is shown for comparison (lower panel). Basic amino acids are labeled in blue, acidic amino acids in red.
Rammelt et al.
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PAPD5, the protein was detected in cells expressing Flag-
tagged PAPD5 with anti-Flag antibody followed by a sec-
ondary antibody conjugated to a fluorescent dye (Fig. 7A).
In addition, PAPD5 fusion proteins with green fluorescent
protein (GFP) fused to the N or C terminus were expressed
transiently (Fig. 7B,C). All fusion proteins were detected in
the nucleus as shown by colocalization of the fluorescence
signals with the DAPI stain, no staining of the cytoplasm
could be observed. The basic stretch of amino acids at the C
terminus of PAPD5 that is involved in RNA binding does
not play a role for localization of PAPD5, because a Flag-
tagged deletion variant corresponding to PAPD5DC, i.e.,
lacking the basic stretch, is still exclusively located in the
nucleus (Fig. 7D).
Ribosomal RNAs are in vivo targets of PAPD5
PAPD5 was able to polyadenylate a variety of RNA sub-
strates in vitro, ranging from oligo(A) and oligo(U) to
different tRNAs as well as the 39 UTR of histone mRNAs.
To determine the potential substrate spectrum of PAPD5
in vivo, RNAs bound to the protein in HEK293 cells were
probed by the PAR-CLIP technique (Hafner et al. 2010).
Briefly, HEK293 cells expressing Flag-tagged PAPD5 were
grown in medium containing 4-thio-uridine and RNA–
protein complexes were UV-cross-linked and immunopre-
cipitated. The covalently bound RNAs were extracted,
adapter oligonucleotides were ligated to the 59 and 39 ends,
and the RNA was reverse-transcribed. The cDNA was am-
plified and the sequences determined by deep sequencing.
We then compared the results obtained in two separate
PAPD5 PAR-CLIP experiments and those previously ob-
tained for the insulin growth factor 2 binding protein 1
(IGF2BP1) (Hafner et al. 2010) to identify genomic regions
from which PAPD5 targets derive. The IGF2BP1 PAR-CLIP
sample contained 24,914,594 reads and the PAPD5 PAR-
CLIP samples 4,949,000 and 5,563,677 reads, respectively.
The proportion of reads mapping with at most one error
to the human genome was 45.64% in the case of IGF2BP1
and 32.77% and 27.13% for PAPD5 replicates. We nor-
malized the count of mapped reads across samples and
calculated the number of reads originating in each 100-nt-
long window of the genome, and the variance of these
counts in the PAPD5 PAR-CLIP replicates with the method
described by Balwierz et al. (2009). We then computed the
Z-score indicating the significance of the enrichment or
depletion in reads in a PAPD5 sample compared to the
IGF2BP1 sample. The distributions of the Z-scores across
all genomic regions (Fig. 8) show a much higher similarity
of PADP5 replicates relative to the IGF2BP1 sample. With
cut-off values of !5 and 5, at which only a very small
number of genomic regions will be considered differen-
tially represented between PAPD5 replicates, we obtained
988 regions for the first PAPD5 replicate and 923 for the
second (Table 2) that were differentially expressed rela-
tive to IGF2BP1. Four hundred thirty-four regions were
differentially expressed between both PAPD5 replicates
and the IGF2BP1 sample. Of these, 358 regions were enriched,
whereas 76 were depleted in PAPD5 samples (Supplemental
Table S1). One hundred ninety-two out of the 358 enriched
windows corresponded to repeat elements, 61 of which
were rRNA. These latter windows were located in genomic
regions annotated as rRNA-like in the Genome Browser of
the University of California Santa Cruz. They contained
FIGURE 5. Mutations in the basic motif of PAPD5 lead to loss of
activity. PAPD5 wild-type protein (wt), C-terminal deletion mutant
(DC, amino acids 1–551), or a point mutant in the basic motif (KE,
position 560) expressed in E. coli were incubated with ribo-oligonu-
cleotide A15 in the presence of ATP.
TABLE 1. Kinetic parameters of PAPD5 variants
Protein
KM (A15)
(mM)
Vmax (A15)
(mmol/min per mg)
kcat (A15)
(min!1)
KM (ATP)
(mM)
Vmax (ATP)
(mmol/min per mg)
kcat (ATP)
(min!1)
PAPD5 wt 0.92 6 0.11 0.15 6 0.01 10.8 63.6 6 8.6 0.083 6 0.002 5.8
PAPD5 DC 5.34 6 0.29 0.13 6 0.06 8.8 64.3 6 8.4 0.023 6 0.010 1.6
PAPD5 KE 3.19 6 0.35 0.12 6 0.02 8.5 46.9 6 6.2 0.023 6 0.002 1.7
EcPAPa 0.39 6 0.10 130 6 80
bovPAPb 1.34 6 0.23 1366 229 6 63 252
aBetat et al. 2004.
bMartin et al. 2004.
The noncanonical poly(A) polymerase PAPD5
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reads that we also annotated as rRNA-derived, based on the
fact that they mapped with at most one error to the rRNA
subunits. In contrast, only two of the 76 regions depleted
in PAPD5 binding had rRNA annotations (Fisher’s exact
test, p < 0.001), indicating that rRNAs could be the primary
targets of PAPD5 in human cells.
DISCUSSION
PAPD5 belongs to the family of Cid1-like proteins or
noncanonical PAPs. In this family of nucleotidyltransferases,
several members do not contain a recognizable RNA-
binding domain. For the noncanonical PAP Trf4p from
yeast, it was shown that nucleotidyltransferase activity can
only be observed for the complex of Trf4p and one of the
two zinc-knuckle proteins Air1p or Air2p, but not for Trf4p
alone (LaCava et al. 2005; Vanacova et al. 2005). Therefore,
it is thought that Trf4p is the catalytic subunit of this
bipartite PAP, whereas the zinc-knuckle proteins confer RNA-
binding specificity to the complex. Such a modular organi-
zation of a catalytic subunit that could even be combined with
different RNA-binding subunits to result in an active nucle-
otidyltransferase may allow the targeting of different classes of
substrates, depending on the RNA-binding subunit used. For
the TRAMP4 complex in yeast, it was shown that two out
of the five zinc knuckles of Air2p are necessary and sufficient
for the polyadenylation of a short RNA oligonucleotide. How-
ever, efficient polyadenylation of a tRNA required the most
N-terminal zinc knuckle in addition. Although the other two
zinc knuckles seem to be dispensable for the tRNA sub-
strate, they may be important for the recognition of other
TRAMP substrates (Hamill et al. 2010).
Surprisingly, PAPD5, a human Trf4p homolog lacking a
recognizable RNA-binding domain, is able to catalyze the
addition of nucleotides to RNA substrates in the absence
of a protein cofactor. Analysis of the amino acid sequence
revealed a stretch of basic residues in the C terminus of
PAPD5 that is highly conserved among higher eukaryotes.
When this motif was deleted, the nucleotidyltransferase
activity was strongly reduced, and both
electrophoretic mobility shift experi-
ments and the analysis of the activity
of a point mutant in this part of the
protein showed the stretch of basic amino
acids to take part in binding of the RNA
substrate. PAPD5 was able to incor-
porate nucleotides to different RNA
substrates [oligo(A), oligo(U), tRNA,
histone mRNA 39 end], therefore the
RNA-binding function is very likely not
sequence-specific, resulting in poly-
adenylation of all RNAs with a free
39-hydroxyl end in vitro. However, like
the yeast TRAMP complex, PAPD5 dis-
criminates between in vitro–synthesized,
unmodified and native, fully modified tRNAs. Very likely,
this is due to a difference in the stability of the RNA
structure, resulting in the 39 end of the in vitro transcript
being more accessible to the poly(A) polymerase. PAPD5
has been shown to be involved in the polyadenylation of
aberrant ribosomal RNAs: Aberrant pre-rRNAs were
found to be partially polyadenylated in a murine cell
line by reverse transcription with an oligo(dT)-adapter
primer followed by PCR with a forward primer specific
for the 59-ETS region of pre-rRNA. After knockdown of
PAPD5, the amount of polyadenylated pre-rRNAs was
decreased (Shcherbik et al. 2010). In agreement with this
finding, the analysis of RNAs cross-linked to PAPD5 in
vivo revealed rRNAs to be potential substrates of PAPD5.
Ribosomal RNAs were represented in the potential RNA
substrates in a high percentage, and they were specifically
enriched in the PAPD5 samples compared to a control
IGF2BP1 sample. The same was shown for Trf4p-associ-
ated RNAs in yeast: 50% of the sequences identified by an
in vivo cross-linking approach were mapped to ribosomal
sequences (Wlotzka et al. 2011). In addition, other classes of
noncoding RNAs as well as pre-mRNAs and mRNAs were
found to be associated with PAPD5. Although in Trf4-deletion
yeast strains as well as in the cross-linking approach the same
classes of RNAs were found to be enriched, the relative
proportions of these transcript types were different from that
found here for PAPD5 (San Paolo et al. 2009; Wlotzka et al.
2011), and in the PAPD5 samples such targets were not
robustly enriched. Whereas in yeast only two noncanonical
poly(A) polymerases are present, human cells contain seven
members of this protein family. Therefore, other noncanon-
ical poly(A) polymerases may be involved in the polyade-
nylation of other aberrant RNAs.
The catalytic parameters observed for the wild-type PAPD5
protein (Table 1) are similar to the values determined for
bacterial poly(A) polymerase, an enzyme also involved in
RNA degradation (Li et al. 1998, 2002). In contrast, canonical
poly(A) polymerases show higher maximal velocity even
under distributive reaction conditions, reflecting the function
FIGURE 6. PAPD5 adds poly(A) tails to the unmodified in vitro transcript of S. cerevisiae
tRNAi
Met, but not to the native tRNA isolated from yeast. PAPD5 protein expressed in E. coli
(PAPD5 rec.) or in HEK293 cells was incubated with the different RNA substrates in the
presence of ATP, and the reactions were stopped after the reaction times indicated (0, 10, 20,
40, 60 min).
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of the two different types of polyadenylation. Whereas the
canonical poly(A) polymerases add long tails that are im-
mediately bound by poly(A)-binding proteins and allow
protection of the mRNA from degradation, polyadenyl-
ation-mediated degradation is characterized by the addition
of short tails as well as distributive polyadenylation to allow
access of the degradation machinery.
In the cell, noncoding RNAs as well as mRNAs are
bound by proteins during processing and reside in RNPs to
perform their function. In contrast, aberrant RNAs or
processing intermediates that—due to misfolding or mis-
processing—cannot form the correct interactions to pro-
tein partners would be accessible for polyadenylation and
degradation. Therefore, PAPD5 could act as a kind of
scavenger enzyme, similar to the TRAMP4 complex in
yeast, to polyadenylate RNA 39 ends and thereby tag the
corresponding RNA for degradation. Like yeast Trf4p,
PAPD5 is located in the nucleus of the cell and may
therefore be part of a nuclear surveillance machinery
similar to the TRAMP4–exosome system of yeast. In
contrast to Trf4p, PAPD5 is able to bind different RNAs,
and when His-Flag-tagged PAPD5 was purified from
mammalian cells, no copurifying RNA-binding proteins
could be identified by mass spectrometry. However, it still
remains to be determined whether protein cofactors are
necessary for the efficient binding of PAPD5 to substrates,
as has been shown for TRAMP4.
When the levels of several of the putative substrates iden-
tified by the CLIP experiments were analyzed in cells treated
with siRNAs directed against PAPD5 or control siRNA, no
significant change could be observed (results not shown).
However, mammalian cells contain genes for seven proteins
of the Cid1-like family. PAPD7, one of these homologs, is
very similar to PAPD5. If more than one of these non-
canonical PAPs are able to target the same RNAs, depletion
of the cell of a single PAP may not lead to a detectable
change in the RNA level. It has been observed for poly(A)
and A-rich tails on human rRNA that the knockdown of
a single noncanonical PAP does not abolish tail addition
(Slomovic et al. 2010). Therefore, the RNA surveillance sys-
tem is most likely redundant, allowing potentially deleterious
aberrant RNAs to be degraded with high efficiency.
MATERIALS AND METHODS
Expression and purification of PAPD5
The coding sequence of PAPD5 was amplified from HeLa cell
cDNA. The ORF was cloned into pcDNA5/FRT for expression as
a fusion protein with N-terminal His8 and Flag tags in mammalian
cells. For expression, an HEK293 cell line, Flp-In-293 (Invitrogen),
was used. Cells were cultivated in DMEM medium containing 10%
fetal calf serum, and cell lines expressing PAPD5 were selected
according to the manufacturer’s instructions. For analysis of the
subcellular localization, PAPD5 was transiently expressed as an
N- or C-terminal GFP fusion protein or with a Flag tag. For de-
tection of Flag-tagged protein, cells were permeabilized, and the
fusion protein was stained with mouse anti-Flag antibody (Sigma)
and Cy3-conjugated donkey anti-mouse antibody (Dianova).
For expression in E. coli, the ORF of PAPD5 was cloned into
pET30 for expression as a fusion protein with an N-terminal
GB1 tag and a C-terminal His6 tag (Zhou et al. 2001) or into
pETDuet (Novagen) for expression as a C-terminal His6-tag
fusion protein. A BL21 (DE3) strain deficient for E. coli poly(A)
polymerase was constructed with the TargeTron Gene Knockout
System (Sigma-Aldrich). The strain was transformed with the
corresponding expression plasmids, grown in LB medium at 37°C
to an OD600 of 0.8, and expression of PAPD5 was induced with
1 mM IPTG for 3 h.
For purification of the protein from mammalian cells, the cells
were lysed by sonication in buffer containing 50 mM Tris (pH 7.5),
100 mM KCl, 10% glycerol, 0,05% NP-40, 1 mM PMSF, 1 mg/L
Pepstatin, and 1 mg/L Leupeptin. The cleared lysate was incubated
FIGURE 7. PAPD5 is located in the nucleus. (A) PAPD5 was
expressed as a fusion protein with N-terminal His8-Flag tag in
HEK293 cells. The protein was detected with anti-Flag antibody and
Cy3-conjugated secondary antibody. Nuclei stained with DAPI (left
panel); the tagged protein signal (middle); the merged picture (right
panel). (B,C) PAPD5 was expressed as a fusion protein with green
fluorescent protein fused to the N terminus (B) or the C terminus (C).
Panels as in A. (D) PAPD5DC (amino acids 1–551) was expressed as
a fusion protein with N-terminal His8-Flag tag in HEK293 cells. The
protein was detected with anti-Flag antibody and Cy3-conjugated
secondary antibody. Panels as in A. DAPI stain of the nucleus (blue),
Cy3 staining (red), and GFP signal (green).
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with M2 anti-Flag agarose (Sigma-Aldrich). The matrix was washed
with lysis buffer containing 300 mM KCl, and the protein was
eluted with lysis buffer containing 5 mM Flag peptide. The eluate was
adjusted to 5 mM imidazole, bound to Ni-NTA agarose (Sigma-
Aldrich), washed with buffer containing 25 mM imidazole, and the
protein was eluted with buffer containing 250 mM imidazole.
The protein expressed in E. coli was purified via metal chelating
chromatography like the protein expressed in mammalian cells,
but the cell lysate was adjusted to 25 mM imidazole, and the
washing buffer contained 500 mM KCl and 50 mM imidazole.
RNA substrates
A plasmid ptRNAMet for the in vitro transcription of yeast
tRNAi
Met was obtained from Dr. Bruno Senger (Institut de
Biologie Mole´culaire et Cellulaire Strasbourg). The plasmid was
linearized with BstNI and transcribed with T7 RNA polymerase.
The native yeast tRNAMet was a gift of Dr. Ge´rard Keith (Institut
de Biologie Mole´culaire et Cellulaire Strasbourg). The plasmid
pUC19-H2a for in vitro transcription of the mouse histone H2a
mRNA 39 end with T7 RNA polymerase was obtained from Dr.
Sophie Jaeger (Biozentrum, University of Basel). In vitro–
transcribed RNAs were purified on 8.3 M urea/10% polyacryl-
amide gels. For 59-end labeling, RNAs were treated with alkaline
phosphatase and labeled with [g-32P]ATP (GE Healthcare) and
T4 polynucleotide kinase. Labeled RNAs were gel-purified. To
allow folding of the structured RNAs, pellets were dissolved in
RNase-free water and incubated for 1 min at 65°C, followed by
incubation for 10 min on ice after the addition of an equal
volume of twice-concentrated assay buffer containing 10 mM
MgCl2.
Polyadenylation assays
Polyadenylation assays were carried out in
20-mL reaction mixtures containing 0.07–0.7
pmol of affinity-purified protein, 1 pmol of
59-end-labeled RNA, 1 mMATP, 5 mMMgCl2,
25 mM Tris-HCl (pH 7.5), 50 mM KCl,
0.01 mM EDTA, 0.1 mg/mL BSA, 1 mM
DTT, and 0.02% NP-40. Reactions were in-
cubated for 30 min at 37°C or the times
indicated and stopped by the addition of 25
mM EDTA. The RNA was precipitated by
addition of 0.1 volume of 3 M ammonium
acetate and three volumes of ethanol. Pellets
were resuspended in formamide loading
buffer and separated on denaturing poly-
acrylamide gels. Radioactivity was scanned
with a PhosphorImager, and results were
analyzed with ImageQuant software (Molec-
ular Dynamics).
For determination of the kinetic param-
eters, the activities of PAPD5 variants were
measured in 20-mL reaction mixtures con-
taining buffer as above with 0.2 mCi of
[a-32P]ATP (3000 Ci/mmol) and 0.7–3.5
pmol (0.035–0.17 mM) recombinant protein.
The concentration of ATP was varied be-
tween 0.01 mM and 1 mM (the concentra-
tion of A15 was kept constant at 2.5 mM), and
the concentration of unlabeled RNA A15 was varied between 50 nM
and 2.5 mM (ATP was kept constant at 1 mM). The reactions were
incubated for 20 min at 37°C and stopped by spotting onto DE-81
paper. The filters were washed three times for 10 min in 0.3 M
ammonium formate/10 mM Na-pyrophosphate, and the incorporated
radioactivity was measured in a scintillation counter.
EMSA
Electrophoretic mobility shift assays (EMSAs) were carried out in
20-mL reaction mixtures containing 0.5–20 nM of affinity-purified
protein, 1 nM 59-end-labeled RNA, 10% glycerol, and 1 mg/L total
yeast RNA in buffer as above. Reactions were incubated for 10 min
at room temperature and separated on a native 6% polyacryl-
amide gel in 0.53 TBE. Radioactivity was scanned with a Phos-
phorImager, and results were analyzed with ImageQuant software
(Molecular Dynamics).
PAR-CLIP
RNAs bound to PAPD5 in vivo were analyzed by the PAR-CLIP
technique essentially as described in Hafner et al. (2010). Flp-In-293
FIGURE 8. Distribution of pairwise Z-scores computed for 100-nt-long windows in pairs of
samples. The reads obtained in two separate PAPD5 PAR-CLIP experiments as well as those
previously obtained for the insulin growth factor 2 binding protein 1 (IGF2BP1) (Hafner et al.
2010) were mapped to the genome. After normalization, the Z-scores, giving a measure of the
differential expression of individual 100-nt-long windows in each pair of experiments, were
calculated.
TABLE 2. Sets of enriched (Z-score > 5) and depleted (Z-score <
!5) 100-nt-long genomic windows comparing PAPD5 replicates
versus IGF2BP1
Pairwise comparison Enriched Depleted Total
PAPD5-1 vs. IGF2BP1 868 120 988
PAPD5-2 vs. IGF2BP1 736 187 923
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cells expressing His8-Flag-PAPD5 were grown in medium contain-
ing 100 mM 4-thiouridine, RNA–protein complexes were cross-
linked by exposure of the cells to UV light (366 nm, 150 mJ/cm2),
and lysed in buffer containing 50 mM HEPES (pH 7.4), 150 mM
KCl, 2 mM EDTA, 1 mM NaF, 0.5% NP-40, 0.5 mM DTT, 1 mM
PMSF, 1 mg/L Pepstatin, and 1 mg/L Leupeptin. After removal
of cell debris by centrifugation, the cleared lysate was incubated
with RNase T1 to allow bound RNAs to be partially digested to an
average size of 40 to 60 nt.
RNA–protein complexes were isolated with M2 anti-Flag an-
tibody (Sigma-Aldrich) coupled to protein G Dynabeads (In-
vitrogen). The RNA–protein complexes were gel-purified, the RNA
was isolated, and linkers were ligated to the 59 and 39 ends of the
RNA (Hafner et al. 2008). After reverse transcription and ampli-
fication, the resulting DNA library was sequenced by Solexa se-
quencing. Mapping of short reads to the genome (hg18 assembly
version from the University of California, Santa Cruz obtained
from hgdownload.cse.ucsc.edu) following adaptor removal was
performed as described (Hafner et al. 2010).
Normalization and multiplicative error model
in PAR-CLIP
To compare the expression of genomic regions across samples, the
number of reads needs to be normalized across samples. With
several types of high-throughput expression profiling approaches
such as SAGE (serial analysis of gene expression), CAGE (cap
analysis of gene expression), and chromatin immunoprecipitation
(ChIP), it has been reported that the number of reads originating
from a genomic position or region has a power-law distribution
(Ueda et al. 2004; Zhang et al. 2008; Balwierz et al. 2009). We found
that the same holds for our PAR-CLIP data, which we then
analyzed as follows. We split the genome into 100-nt-long windows
and calculated the number of reads originating in each of these
regions in the IGF2BP1 CLIP samples obtained by Hafner et al.
(2010) and in our two PAPD5 replicates. The reverse cumulative
distribution of the read count in a window (showing the number of
windows with a read count at least as high as a given value, which is
indicated on the x-axis) was power-law-distributed, as expected
(Supplemental Fig. S1A). We standardized these distributions by
transforming them to a reference power law distribution with slope
!1.25 and a total copy of 1 million reads, as described (Balwierz
et al. 2009). The resulting normalized reverse cumulative distri-
butions are shown in Supplemental Figure S1B. Based on the
normalized read counts, we estimated the variance in read count
per window between the PAPD5 replicates to be 0.41. In contrast,
the variances between first and second PAPD5 replicates and
IGF2BP1 were estimated to be 0.91 and 1.03, respectively.
Enrichment and depletion of reads in genomic regions
in PAR-CLIP
Using the estimated variance above, we calculated the Z-scores for
the difference in expression between PAPD5 reads and IGF2BP1
reads in 100-nt-long overlapping genomic windows as described
in Balwierz et al. (2009). Inspecting the pairwise Z-score distri-
butions, we chose a cut-off value of 5 and !5 for regions that are
enriched and depleted, respectively, in the PAPD5 relative to the
IGF2BP1 samples.
Annotation of the sequences
To determine whether the enriched or depleted regions over-
lapped known elements of the genome, we intersected the genome
coordinates of the regions with those of annotated functional
elements (UCSC RepeatMasker, mRNA and noncoding RNA
tracks for hg18 assembly version) (Smit et al. 1996-2010; Pruitt
et al. 2005; Lestrade and Weber 2006; Griffiths-Jones et al. 2008). If
the overlap was at least 20 nt, we transferred the annotation of the
genomic element to the region that was enriched/depleted in CLIP
(Supplemental Table S1).
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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